From June 7, 2022 to July 6, 2022, the company has repurchased 39,777 shares, representing 0.66% for KRW 4,574.17 million. With this, the company has completed the repurchase of 39,777 shares, representing 0.66% for KRW 4,574.17 million under the buyback announced on June 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
127,500 KRW | -0.39% | -4.35% | -47.10% |
03-21 | Medy-Tox Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
01-05 | South Korean Shares Close Marginally Lower on North Korea's Artillery Shells Firing | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.10% | 629M | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- A086900 Stock
- News Medy-Tox Inc.
- Tranche Update on Medy-Tox Inc.'s Equity Buyback Plan announced on June 7, 2022.